Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
02/2010
02/11/2010US20100035923 Vr1 vanilloid receptor antagonists with a iononic substructure
02/10/2010EP2150534A1 Isoquinolinone derivatives as nk3 antagonists
02/09/2010US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds
02/09/2010US7659400 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
02/09/2010US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
02/09/2010CA2268403C Anthranilic acid derivatives as multi drug resistance modulators
02/04/2010US20100029658 Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof
02/04/2010US20100028936 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers
02/04/2010US20100028807 Imide Compound and Chemically Amplified Resist Composition Containing The Same
02/03/2010EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
02/03/2010EP2149560A1 1-substituted tetrahydroisoquinoline compound
02/03/2010EP2149559A1 A process for the preparation of hexahydroisoquinolines from 1,2,3,4-Tetrahydroisoquinolines
02/03/2010CN101638387A A process for the preparation of hexahydroisoquinolines from 1, 2, 3, 4-tetrahydroisoquinolines
02/03/2010CN101638386A Improved preparation of 3, 4-dihydroisoquinolines from an acid and an amine
02/03/2010CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/02/2010CA2442478C Use of group i mglur antagonists in the treatment of fragile x syndrome, autism, mental retardation
01/2010
01/28/2010WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010WO2010010174A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
01/28/2010WO2009124962A3 Sulfonamides
01/28/2010US20100022776 Preparation of Hexahydroisoquinolines from Dihydroisoquinolines
01/28/2010US20100022775 Process for the preparation of rho-kinase inhibitor compounds
01/28/2010US20100022582 Tetrahydroisoquinoline Compound and Medicinal Use Thereof
01/28/2010US20100022514 Heterocycle Compounds and Methods of Use Thereof
01/28/2010US20100022486 Compounds
01/28/2010CA2731869A1 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
01/28/2010CA2730208A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
01/26/2010US7652141 Immunosuppressants, analgesics, antiinflammatory agents
01/26/2010US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
01/26/2010CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
01/21/2010US20100016596 Process for the purification of neuromuscular blocking agents
01/21/2010US20100016309 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparation Process therefor and Pharmaceutical Composition Containing the Same
01/20/2010EP2144881A1 Isoquinolinone derivatives, processes for their preparation and their use in the treatment of chronic obstructive pulmonary disease ( copd ) and asthma
01/20/2010CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
01/19/2010US7649085 Saquinavir conjugates and antibodies useful in immunoassay
01/19/2010CA2402751C Decahydro-isoquinolines
01/14/2010WO2010005087A1 Amidine derivative
01/14/2010WO2009121872A3 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/14/2010US20100010226 Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100009960 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
01/13/2010EP2143714A1 Tetrahydroisoquinoline compound
01/13/2010EP2142510A1 Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
01/13/2010EP2035385B1 Inhibitors of akt (protein kinase b)
01/13/2010EP1910298B1 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
01/07/2010US20100004241 Non-imidazole aryloxyalkylamines
01/07/2010US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
01/06/2010CN101619038A Isoquinoline compound or salt thereof, medicinal composition, preparation method and application thereof
01/05/2010CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
12/2009
12/31/2009US20090325962 Tyrosine derivative
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/30/2009WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009WO2009156099A1 6-substituted isoquinolines and isoquinolinones
12/30/2009WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/30/2009EP2138482A1 Bicyclic heterocyclic compound
12/30/2009CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009CA2728137A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009CA2728128A1 6-substituted isoquinolines and isoquinolinones
12/30/2009CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/29/2009US7638635 Using alkylmetal reagents for directed metalation of azaaromatics
12/29/2009US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009CA2348993C Substituted phenethylsulfones and method of reducing tnf.alpha. levels
12/24/2009US20090318423 Ion Channel Modulators & Uses Thereof
12/24/2009US20090314990 Novel triphenylamine derivatives useful as fluorophores in biology, in particular for two-photon microscopy
12/23/2009EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009CN101611012A Cycloalkylamine substituted isoquinoline derivatives
12/23/2009CN101607938A Novel isoquinoline anti-tumor compound and preparation method thereof
12/23/2009CN100572360C Isoquinoline compound and its salt preparation method and application
12/22/2009US7635703 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases
12/22/2009CA2346563C Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides
12/22/2009CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
12/17/2009US20090312324 Compositions and Methods Related to RAD51 Inactivation in the Treatment of Neoplastic Diseases, and Especially CML
12/16/2009EP2132181A1 (1r,1'r)-atracurium salts separation process
12/16/2009CN101602725A Hexahydroisoquinoline-1-keto compound and synthetic method thereof
12/15/2009US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS
12/15/2009CA2393437C Exo-s-mecamylamine formulation and use in treatment
12/10/2009US20090306390 Chiral ligands, their preparation and uses thereof in asymmetric reactions
12/10/2009US20090306130 Novel tetrahydro-isoquinolines
12/10/2009US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
12/09/2009CN101600698A Quinazolinone and isoquinolinone acetamide derivatives
12/09/2009CN101597259A Organic material and application thereof in organic electroluminescence device (OELD)
12/09/2009CN100567268C Process for synthesis of amine ethers from secondary amino oxides
12/08/2009US7629358 For therapy of inflammatory, allergic and respiratory diseases
12/08/2009US7629357 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents
12/08/2009CA2388475C Preparation of chiral 1,2,3,4-tetrahydro-6,7-dialkoxy-3-isoquinolinecarboxylic acid and derivatives
12/03/2009US20090298825 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
12/02/2009EP2125745A1 Cycloalkylamine substituted isoquinolone derivatives
12/02/2009EP2125744A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives
12/02/2009EP2125743A1 (1r,1'r)-atracurium salts separation process
12/02/2009EP2125742A2 (1r,1'r)-atracurium salts separation process
12/02/2009EP2124562A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/02/2009EP1965805B1 Urea derivatives useful as calcium receptor modulators
12/02/2009EP1812399B1 Opiate intermediates and methods of synthesis
12/02/2009CN101595094A Cycloalkylamine substituted isoquinolone derivatives
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 119